Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Letrozole 23 Docetaxel 17 Cyclophosphamide 13 Zoledronic Acid 12 Trastuzumab 12 Anastrozole 12 exemestane 11 Tamoxifen 11 Paclitaxel 11 Capecitabine 10 Fulvestrant 8 Epirubicin 8 pegfilgrastim 7 Saline Solution 7 Bupivacaine 7 pertuzumab 6 liposomal doxorubicin 6 abemaciclib 6 Sodium Chloride 6 Filgrastim 6 Carboplatin 6 pegylated granulocyte colony-stimulating factor 5 palbociclib 5 Ropivacaine 5 Dexmedetomidine 5 Bevacizumab 5 ribociclib 4 eribulin 4 Vinorelbine 4 Tranexamic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × 1-dodecylpyridoxal × Breast × Clear all

NCT03123770 2019-04-10

ESNDBCP

Zhejiang University

Phase 4 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡